Literature DB >> 15144118

Toward an understanding of the long-term outcome of juvenile idiopathic arthritis.

A Ravelli.   

Abstract

Over the past four decades, a number of studies have evaluated the long-term outcome of juvenile idiopathic arthritis (JIA) and some of them have also attempted to identify early prognostic factors. This editorial addresses, by reviewing the surveys that have analyzed the outcome of JIA in term of clinical remission, physical disability, and radiographic damage, the clinical questions that are most relevant in this area of study. Altogether, the available data indicate that JIA is not a benign disease because a considerable number of patients still enter adulthood with persistently active disease and a significant proportion of them may develop severe physical disability. Among the different onset forms, the long-term outcome is best in persistent oligoarthritis and worst in RF-positive polyarthritis; the outcome of systemic arthritis is widely variable, perhaps reflecting the heterogeneity of this JIA subtype. The comparison of earlier studies with those published in the last decade shows a decline in the frequency of patients with severe physical disability over the years; however, the proportion of patients who enter adulthood with active disease does not seem to be diminished. Although there is considerable data on prognostic factors in JIA, prediction of long-term outcome early after disease presentation is still difficult because comparisons among studies are hindered for a variety of reasons. Thus, while a considerable body of data is accumulating, the definition of the long-term outcome of JIA remains imperfect. To increase the comparability of future analyses and to obtain generalizable information on the prognosis of JIA and its prediction, a great deal of effort should be directed toward standardizing the study design and the measurement of predictors and outcomes.

Entities:  

Mesh:

Year:  2004        PMID: 15144118

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  23 in total

Review 1.  Uveitis in juvenile idiopathic arthritis.

Authors:  Arnd Heiligenhaus; Kirsten Minden; Dirk Föll; Uwe Pleyer
Journal:  Dtsch Arztebl Int       Date:  2015-02-06       Impact factor: 5.594

Review 2.  Familial Mediterranean fever and ankylosing spondylitis in a patient with juvenile idiopathic arthritis: A case report and review of the literature.

Authors:  Işik Keleş; Gülümser Aydin; Aliye Tosun; Elem Inal; Hatice Keleş; Sevim Orkun
Journal:  Rheumatol Int       Date:  2005-11-24       Impact factor: 2.631

3.  Juvenile idiopathic arthritis in the biologic era: predictors of the disease progression and need for early introduction of biologic treatment.

Authors:  Panayiota Nalbanti; Florentia Kanakoudi-Tsakalidou; Maria Trachana; Polyxeni Pratsidou-Gertsi; Evangelia Farmaki; Panagiotis Bamidis; Fotios Papachristou
Journal:  Rheumatol Int       Date:  2018-05-29       Impact factor: 2.631

Review 4.  Heading toward a modern imaging approach in juvenile idiopathic arthritis.

Authors:  Stefano Lanni; Alberto Martini; Clara Malattia
Journal:  Curr Rheumatol Rep       Date:  2014-05       Impact factor: 4.592

5.  Evaluation of children with juvenile idiopathic arthritis in southeastern Turkey: a single center experience.

Authors:  V Şen; A Ece; Ü Uluca; A Güneş; S Yel; I Tan; D Karabel; B Yıldırım; K Haspolat
Journal:  Hippokratia       Date:  2015 Jan-Mar       Impact factor: 0.471

6.  Attitudes of rheumatology practitioners toward transition and transfer from pediatric to adult healthcare.

Authors:  Deborah Hilderson; Philip Moons; Rene Westhovens; Carine Wouters
Journal:  Rheumatol Int       Date:  2011-12-23       Impact factor: 2.631

Review 7.  Macrophage activation syndrome and cytokine-directed therapies.

Authors:  Grant S Schulert; Alexei A Grom
Journal:  Best Pract Res Clin Rheumatol       Date:  2014-04       Impact factor: 4.098

8.  Clinical analysis in 202 children with juvenile idiopathic arthritis.

Authors:  Hui Huang; Xiaoqing Qian; Haiguo Yu; Juan Li; Yayuan Zhang
Journal:  Clin Rheumatol       Date:  2013-03-21       Impact factor: 2.980

9.  Seeking insights into the EPidemiology, treatment and Outcome of Childhood Arthritis through a multinational collaborative effort: Introduction of the EPOCA study.

Authors:  Alessandro Consolaro; Nicolino Ruperto; Giovanni Filocamo; Stefano Lanni; Giulia Bracciolini; Marco Garrone; Silvia Scala; Luca Villa; Giuseppe Silvestri; Daniela Tani; Alessandra Zolesi; Alberto Martini; Angelo Ravelli
Journal:  Pediatr Rheumatol Online J       Date:  2012-11-20       Impact factor: 3.054

10.  Nitric oxide levels and the severity of juvenile idiopathic arthritis.

Authors:  Blanca Elena R G Bica; Niele M Gomes; Patrícia D Fernandes; Ronir R Luiz; Vera Lúcia G Koatz
Journal:  Rheumatol Int       Date:  2007-02-08       Impact factor: 3.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.